Feb 10, 2010
By:
Jill Wechsler
Added funds for FDA to come from new user fees, largely for food and tobacco regulation.
|
Feb 1, 2010
By:
Jill Wechsler
R&D is surging, but new methods and data raise new manufacturing and regulatory challenges.
|
|
Jan 6, 2010
By:
Jill Wechsler
FDA Commissioner Margaret Hamburg has a history of health advocacy and a clear mandate to transform the agency. But can she succeed where others have failed?
|
Jan 1, 2010
By:
Jill Wechsler
Pharma must confront regulatory and marketing challenges in a global competitive environment.
|
Dec 1, 2009
By:
Jill Wechsler
They already dominate the pharmaceutical market, and now generics are poised to move into biologics and complex dosage forms.
|
Nov 24, 2009
By:
Jill Wechsler
House bill boosts rebates and opens the door to government price negotiations.
|
Nov 1, 2009
By:
Jill Wechsler
FDA and Congress weigh policies for improving drug safety via ads and written information.
|
Oct 1, 2009
By:
Jill Wechsler
All the focus on drug safety raises concerns about FDA delays in approving new drugs for market.
|
Sep 1, 2009
By:
Jill Wechsler
Pharma steps up development of new vaccines and treatments to combat Third World diseases
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
